BLUU is a German biotechnology company that grows fish cells in bioreactors and supplies ingredient components made from them. It calls itself a business-to-business ingredient company that works with partners who formulate and commercialise products. Seafood is one of three target categories, next to marine bio-actives for health and for skincare.
Fish-cell platform and process
The company cultivates proprietary salmonid cells and treats them as a stable biological input. Its website describes four steps: cells, cultivation, concentration and components. Cells are taken from a defined, traceable source, grown under monitored conditions to increase biomass, concentrated to raise the density of functional material and then processed into defined ingredient components or bio-actives.
BLUU says the cell lines are non-GMO and selected for long-term repeatability. It also states that salmonid cells form a naturally co-expressed network of more than 7,000 proteins and more than 4,000 metabolites. For a food developer, this indicates a complex mixture rather than a single compound, so composition and batch consistency are the main questions.
A tool called the Protein Explorer lets partners browse the proteome and metabolome of the cells, along with in vitro efficacy data. Food technologists will value access to composition data, though in vitro results for wound healing or skin do not translate directly to taste, texture or nutrition in a food matrix.
Scale and development status
The company reports a completed 1,000 litre production run achieved with a partner and names 2,000 litres as the next milestone for 2027. It also states that it raised more than 30 million euros from private capital and public support, and that process optimisation and media improvements have cut costs by more than 80 percent.
Cultivated seafood in the food category is described as a long-term opportunity with an established regulatory pathway. Meanwhile the company states that personal care actives are first to market, with partner evaluations active, and health bio-actives follow a documentation-first path. A food buyer should therefore expect development collaboration and not a catalogue product with a price list.
The company says its approach to scale relies on control and reliability, with defined process windows, quality systems and traceability. It describes partner-led scaling, which means it intends to integrate with established industrial partners rather than build all capacity itself. Buyers should ask who would operate production at commercial volumes and which party would hold the regulatory submissions.
Food applications and evaluation
In food, the company says it develops fish-cell-derived ingredient components that help partners create seafood products with more consistency, reliability and supply confidence. It lists a seafood-relevant sensory contribution and marine-relevant nutrition among the design aims. The model is ingredient-first: BLUU supplies components, and partners build the brands, so the buyer remains responsible for the finished product.
Cell-based ingredients can be used in two ways. A small share of fish cells can be blended into a plant-based or fermentation-derived base to add flavour and marine character, or cells can serve as the main structural mass of a product. Background on these formats is on the pages for cultivated seafood and cultivated meat.
Approval is the gating item. Cell-based food needs pre-market authorisation in most jurisdictions, and the company states that a regulatory pathway is established. A developer should ask which markets have been approached, what dossier work exists and which data are already available, since an unapproved ingredient cannot be sold in a product regardless of sensory quality.
For evaluation, request a specification for any component offered for food, with protein share, fat, moisture, ash and microbiological limits. Ask which cell type, growth medium and processing aids are used, because medium components affect allergen status and labelling. Request sample quantities, a development timeline, and indicative cost ranges per kilogram, and compare them with fish protein or plant-based alternatives.
The company lists quality management and an environmental, social and governance officer on its team, and it offers separate contact routes for investment, partnership, press and careers. A buyer should open the partnership route, state the intended application and volume, and ask for a joint development plan with milestones, confidentiality terms and clear ownership of any formulation developed together.